The acceptability, safety and tolerability of combined methadone-naloxone in methadone maintained individuals aged between 18 - 65

Phase 2

Completed

• Conditions: Participants are opiod dependant and methadone maintained individuals aged between 18-65; Mental Health - Addiction

• Registration Number: ACTRN12608000024347
• Lead Sponsor: angton Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-01-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Opioid dependent clients;
• In treatment for greater than 2months
• Stabilised on current dose for greater than 4 weeks
• Willing to remain on current dose for duration of the trial
• Venous access
• Able to provide voluntary informed consent

Exclusion Criteria

• Considered unwilling, unable or unlikely to comply with the study protocol
• Lactating and pregnant women
• Active psychotic illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified